NHFT Contraceptives Formulary January 2017
|
|
- Marlene Simon
- 5 years ago
- Views:
Transcription
1 NHFT Contraceptives Formulary January 201 Contents Contraceptives... 2 Combined hormonal contraceptives... 2 Progestogen-only contraceptives... 2 Contraceptve devices... 3 Emergency Contraception... 3 Table of Oral Contraceptive Preparations December Page 1 of 6
2 Contraceptives Combined hormonal contraceptives Oral preparations - See table below (sections 1-) Transdermal (Standard strength) with norelgestromin patches (Evra ) Vaginal (low strength) with Etonogestrel (NuvaRing ) Progestogen-only contraceptives Oral progestogen-only contraceptives See table below (section 8) Parenteral progestogen-only contraceptives Injectable preparations Medroxyprogesterone acetate 10mg in 1ml pre-filled syringe (Depo-Provera ) Medroxyprogesterone acetate 104mg in 0.6ml pre-filled injector device (Sayana Press ) enantate 200mg/ml oily injection (Noristerat ) Implants Etonogestrel 68mg flexible rod (Nexplanon ) Intra-uterine progestogen-only device 2mg device (Mirena ) 13.mg device (Jaydess ) Page 2 of 6
3 Contraceptve devices Intra-uterine contraceptive devices T-safe Cu 380A T-Safe Cu 380A (QL) QuickLoad Emergency Contraception 1.mg tablet Levonelle One Step Levonelle 100 Ulipristal acetate 30mg tablet (ellaone ) Intra-uterine device (see previous) Page 3 of 6
4 Table of Oral Contraceptive Preparations December 2016 Type of preparation (1)Monophasic low strength (-day (2)Monophasic standard strength (-day (3)Monophasic standard strength (28-day Every day Oestrogen 20 micrograms 20 micrograms 20 micrograms Mestranol 0 micrograms Progestogen Desogestrel 10 micrograms acetate 1 mg Desogestrel 10 micrograms Tablets per cycle Equivalent Brands Gedarel 20/10 Lestramyl 20/10 Mercilon Munalea 20/10 Aidulan 20/ Femodette Millinette 20/ Sunya 20/ Loestrin 20 Drospirenone 3 mg 10 micrograms acetate 1. mg Norgestimate 20 micrograms Alenova Cimizt Gedarel 30/10 Lestramyl 30/10 Marvelon Munalea 30/10 Cleosensa Lucette Yasmin Aidulan 30/ Femodene Katya 30/ Millinette 30/ Elevin Erlibelle Maexeni Levest Microgynon 30 Ovranette Rigevidon Loestrin 30 Cilest Lizinna Brevinor Ovysmen 1 mg Norimin 1 mg Norinyl-1 10 micrograms active & inactive active & inactive Femodene ED Microgynon 30 ED Page 4 of 6
5 Type of preparation Oestrogen Progestogen Tablets per cycle Equivalent Brands (4)Monophasic (28- day Every day preparation) Estradiol (as hemihydrate) 1. mg Nomegestrol acetate 2. mg 24 active & 4 inactive Zoely 0 micrograms 6 40 micrograms 0 micrograms Triadene 100 micrograms 10 0 micrograms 6 40 micrograms Logynon TriRegol 12 micrograms 10 ()Phasic standard strength (-day 1 mg 14 BiNovum 1 mg 9 Synphase 0 micrograms TriNovum 1 mg 0 micrograms 6 (6)Phasic standard strength (28-day Every day preparation) 40 micrograms 12 micrograms 10 Logynon ED inactive Page of 6
6 Type of preparation Oestrogen Progestogen Tablets per cycle Equivalent Brands 3 mg Dienogest 2 mg 2 ()Phasic (28-day Every day preparation) 2 mg 2 mg 1 mg Dienogest 3 mg 1 2 Qlaira 2 inactive 28 Aizea 28 Cerazette 28 Cerelle Desogestrel 28 Desomono 28 Desorex (8) Progesterone Only 28 Feanolla 28 Nacrez 28 Zelleta 30 micrograms 3 Norgeston 30 micrograms 28 Micronor 28 Noriday Page 6 of 6
Hormonal contraception: NHS Tayside Formulary, pharmacological content and other characteristics
Hormonal contraception: NHS Tayside Formulary, pharmacological content and other characteristics Advice from the Tayside Sexual & Reproductive Health Service (TSRHS) (Last update: 10/2017) Combined hormonal
More informationSCOTTISH DRUG TARIFF ANNEX B: PRESCRIPTION CHARGES
SCOTTISH DRUG TARIFF PART 1 ANNEX B: PRESCRIPTION CHARGES From 1 st April 2011 the prescription charge in Scotland has been abolished. Any Scottish prescription form presented for dispensing in Scotland
More informationSCOTTISH DRUG TARIFF ANNEX B: PRESCRIPTION CHARGES
SCOTTISH DRUG TARIFF PART 1 ANNEX B: PRESCRIPTION CHARGES From 1 st April 2011 the prescription charge in Scotland has been abolished. Any Scottish prescription form presented for dispensing in Scotland
More informationBradford Contraception and Sexual Health Services FORMULARY
Bradford Contraception and Sexual Health Services FORMULARY Medication Stock Item Strength Form Pack Size Indication Acetone Liquid 50ml For lab use Aciclovir TTO (PGD) 400mg Tablets 15 Herpes Treatment
More information7: Obstetrics, gynaecology, and urinary tract disorders
Original Date of issue: 31/12/2005 Last eviewed: 11/11/2011 Version:4 Page 1 of 6 7: Obstetrics, gynaecology, and urinary tract disorders 7.1 Drugs used in obstetrics 7.1.1 Prostaglandins and oxytocics
More informationInfections of the genito-urinary system and sexually transmitted diseases Please refer to the Treatment of infections in Primary Care section
Genito-urinary System Infections of the genito-urinary system and sexual transmitted diseases - Please refer to the Treatment of infections in Primary Care section Combined Hormonal Contraceptives Combined
More informationVolume 8; Number 7 April 2014
Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire
More informationSIDE EFFECT MANAGEMENT
SIDE EFFECT MANAGEMENT SIDE EFFECT MANAGEMENT Side effects usually diminish within 3 months with continued use of same method 17 Reassure & educate patients to help establish realistic expectations & decrease
More informationMedications & Mothers Milk 2017
See Monograph for Details Alesse, Aviane, Lessina, Levlite, Lutera, Sronyx Monophasic Ethinyl estradiol 20 mcg Levonorgestrel 0.1 mg Angeliq Monophasic Estradiol 1 mg Drospirenone 0.5 mg Approved in Europe
More informationOral Contraceptives. Mike Williams GPST2
Oral Contraceptives Mike Williams GPST2 Curriculum Mechanism Efficacy Advantages/Disadvantages Starting Continuing Problems/complications Contraception: effectiveness rates, risks, benefits and appropriate
More informationIncreasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland
Increasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland Dr Audrey Brown Dr Alison Bigrigg Greater Glasgow and Clyde Long-acting reversible
More informationrequesting information regarding Rebate and QIPP prescribing schemes in NHS Canterbury and Coastal Clinical Commissioning Group
July 2015 Our Ref: FOI.15.CAN0059 requesting information regarding Rebate and QIPP prescribing schemes in NHS Canterbury and Coastal Clinical Commissioning Group Could you please provide me with the details
More informationBeneficiary Advisory Panel Handout Uniform Formulary Decisions June 2006
Beneficiary Advisory Panel Handout Uniform Formulary Decisions June 2006 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical-effectiveness
More informationrequesting information regarding Referral target schemes for GPs in NHS Ashford Clinical Commissioning Group
August 2015 Our Ref: FOI.15.ASH0102 requesting information regarding Referral target schemes for GPs in NHS Ashford Clinical Commissioning Group a) Does the CCG currently operate any schemes for GPs which
More informationContraception and Kidney Problems: Advice for Young Adults
Contraception and Kidney Problems: Advice for Young Adults Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationOral Hormonal Contraceptive Agent Formulary Positioning: (Current as of 5/2017) Aviane Y F $ Orsythia Y F $ Falmina Y F $18.
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Hormonal Contraception P&T DATE: 5/9/2017 CLASS: Endocrine REVIEW HISTORY 2/16 LOB: Medi-Cal (MONTH/YEAR) This policy has
More informationArticle Title: Period Prevalence and Perceived Side Effects of Hormonal Contraceptive Use and the Menstrual Cycle in Elite Athletes
Note. This article will be published in a forthcoming issue of the. The article appears here in its accepted, peer-reviewed form, as it was provided by the submitting author. It has not been copyedited,
More informationCONTRACEPTION AND MISCONCEPTIONS CONTRACEPTION IN WOMEN WITH MENTAL ILLNESS
CONTRACEPTION AND MISCONCEPTIONS CONTRACEPTION IN WOMEN WITH MENTAL ILLNESS OVERVIEW Hormones and mood How mental illness impacts on contraceptive choice Ideal contraception Pro and cons of contraceptive
More informationPreventive Services: Covered Contraceptive Products for Washington
PHARMACY SERVICES Preventive Services: Covered Contraceptive Products for Washington Find out if your medication is on the list We are committed to empowering you to know your coverage options for preventive
More informationHormone Products for Postmenopausal Use in the United States and Canada
Hormone Products for Postmenopausal Use in the United States and Canada Copyright The North American Menopause Society October 25, 2011 Table 1. Oral ET products for postmenopausal use in the United States
More informationManagement of Emergency Contraception (EC)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Management of Emergency Contraception (EC) The risks and benefits of an IUD or oral EC should be discussed and documented (see appendix). Reasonable measures
More informationREPRODUCTIVE HEALTH REPRODUCTIVE HEALTH
REPRODUTIVE HELTH REPRODUTIVE HELTH 147 B D F E G ondoms Lubricated LifeStyles Lubricated Premium ondoms Latex, 144/box. LifeStyles () 046361 Box LifeStyles Extra-Strength Lubricated ondoms Latex, extra-strength,
More informationContraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine
Contraception Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Disclosures No financial relationships to disclose I have no commercial, financial, research ties to
More informationFuture methods of fertility regulation
Future methods of fertility regulation Catherine d Arcangues, d Ph.D., M.D. Department of Reproductive Health and Research World Health Organization Training in Reproductive Health Research Geneva 2006
More informationEfficacy and side-effects of oral contraceptives
DRUG REVIEW Efficacy and side-effects of oral contraceptives ANNE MACGREGOR For the majority of women, oral contraception is safe, convenient and effective, but users should be counselled about potential
More informationOne-day Essentials Contraception. Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire
One-day Essentials Contraception { Dr Paula Briggs, General Practitioner, Clinical Lead Community Sexual Health, Sefton and West Lancashire 80% women access contraception from their GP Therefore it is
More informationD e p o p r o v e r a i n j e c t i o c a l e n d a r
D e p o p r o v e r a i n j e c t i o c a l e n d a r 2 0 1 6 5-10-2016 Depression may be a potential adverse effect of hormonal birth control use, a new study suggests. The Depo - Provera shot is an injection
More informationReview Use of the new progestogens in contraception and gynaecology
The Obstetrician & Gynaecologist 10.1576/toag.8.4.229.27272 www.rcog.org.uk/togonline 2006;8:229 234 Review Review Use of the new progestogens in contraception and gynaecology Author Diana Mansour Key
More informationREPRODUCTIVE HEALTH 159
REPRODUTIVE HEALTH 159 A E D F ondoms Lubricated LifeStyles Lubricated Premium ondoms Latex, 144/box. LifeStyles (A) 046361 ox LifeStyles Extra-Strength Lubricated ondoms Latex, extra-strength, 144/box.
More informationProgestogen only Contraception
Progestogen only Contraception Public Health Commissioned Service delivered by Community Pharmacies Jo Sutton Senior Commissioning Manager Long Term Care, Health and Treatment, Cheshire East Council Dr
More informationClinical Challenges in Contraception. Disclosures. Objectives Pharmacists 4/3/2018
Clinical Challenges in Contraception Kathleen Besinque, PharmD Sarah McBane, PharmD Disclosures Kathleen Besinque has nothing to disclose Sarah McBane has nothing to disclose Objectives Pharmacists Compare
More informationlevonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer
levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer 6 March 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises
More informationLearning objectives. Some fun facts. Presenter Disclosure Information. Become familiar with the newest contraceptive options available
8:45 9:30 am Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin
More informationOral contraception in Denmark
A C TA Obstetricia et Gynecologica AOGS MAIN RESEARCH ARTICLE Oral contraception in Denmark 1998 2010 NADIA M. WILSON 1, MAJA LAURSEN 2 & ØJVIND LIDEGAARD 1 1 Gynecological Clinic, Rigshospitalet University
More informationContraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016
Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016 Disclosure I am a Nexplanon trainer for Merck. Objectives Understand how obesity may affect pharmacokinetics
More informationFemale sex steroids and contraceptives agents
Female sex steroids and contraceptives agents Female Sex Hormones Sex hormones produced by the gonads are necessary for conception, embryonic maturation, and development of primary and secondary sexual
More informationLearning objectives. Some fun facts. Presenter Disclosure Information. Discuss the newest contraceptive options available
2:15 3pm Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin Batur,
More informationLET S TALK PREVENTION
LET S TALK PREVENTION YOUR NO-COST PRESCRIPTION DRUGS FOR PREVENTIVE CARE Your health plan offers certain preventive service benefits at no cost to you. This means you don t have to pay a copay* or coinsurance,
More informationTrudy Bush Lecture: Using Progestins in Clinical Practice. Progestins in Clinical Practice: Outline. NAMS Definitions. FDA Approved Oral Progestins
1 Women's Health 2015: The 23rd Annual Congress FRIDAY, April 17, 2015 Trudy Bush Lecture: Using Progestins in Clinical Practice Commercial Disclosure: I am a consultant on litigation relating to the Mirena
More informationAffordable Care Act Covered Contraceptive Products
PHARMACY SERVICES Affordable Care Act Covered Contraceptive Products Find out if your medication is on the list We are committed to empowering you to know your coverage options for preventive care and
More informationPreventive Services: Covered Contraceptive Products for Oregon
PHARMACY SERVICES Preventive Services: Covered Contraceptive Products for Oregon Find out if your medication is on the list We are committed to empowering you to know your coverage options for preventive
More informationPreventive Services: Covered Contraceptive Products for Utah
PHARMACY SERVICES Preventive Services: Covered Contraceptive Products for Utah Find out if your medication is on the list We are committed to empowering you to know your coverage options for preventive
More informationThrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor
Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service
More informationWHAT ARE CONTRACEPTIVES?
CONTRACEPTION WHAT ARE CONTRACEPTIVES? Methods used to prevent fertilization *Also referred to as birth control methods With contraceptives, it is important to look at what works for you and your body.
More informationClinical Policy: Goserelin Acetate (Zoladex) Reference Number: ERX.SPA.145 Effective Date:
Clinical Policy: (Zoladex) Reference Number: ERX.SPA.145 Effective Date: 10.01.16 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More informationISPUB.COM. Contraception: What s New? Literature Review. P Reshi OVERVIEW COMBINED ORAL CONTRACEPTIVES DROSPIRENONE
ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 11 Number 1 P Reshi Citation P Reshi.. The Internet Journal of Gynecology and Obstetrics. 2008 Volume 11 Number 1. Abstract This article
More informationContraceptive Technology Past, Present & Future
ICCR 100 TH MEETING: 42 YEARS OF ACHIEVEMENT Contraceptive Technology Past, Present & Future Regine Sitruk-Ware, MD Population Council 20 April 2012 New York, NY USA The International Committee for Contraceptive
More informationStatus Update on the National Cardiovascular Prevention Guidelines - JNC 8, ATP 4, and Obesity 2
TABLE OF CONTENTS Status Update on the National Cardiovascular Prevention Guidelines 1 Drosperinone-Containing Oral Contraceptives and Venous Thromboembolism Risk 1-4 P&T Committee Formulary Action 5 Status
More informationReviewer No.2 Commentary: contraceptive medicines: does choice make a difference?
Reviewer No.2 Commentary: contraceptive medicines: does choice make a difference? The detailed review by Andrew Gray and colleagues (Systematic review of contraceptive medicines: does choice make a difference?
More information100% Highly effective No cost No side effects
effective? Advantages Disadvantages How do I get Cost Abstinence For some it can mean no sexual contact. For others it is no sexual intercourse or vaginal penetration. A permanent surgical procedure available
More informationMenopause. Medicines To Help You
Medicines To Help You Menopause Use this guide to help you talk to your doctor, pharmacist, or nurse about your hormone medicines. The guide lists all of the FDA-approved products now available to treat
More informationGuidance on Bioequivalence Studies for Reproductive Health Medicines
Guidance on Bioequivalence Studies for Reproductive Health 1 TABLE OF CONTENTS 1. Introduction... 3 2. Which products require a bioequivalence study?... 4 3. Design and conduct of bioequivalence studies...
More informationTopic 24: Estrogens and Female Reproductive Drugs
Topic 24: Estrogens and Female Reproductive Drugs I. Contraceptives A. Estrogen-Progestin Contraceptives Note all of these drugs contain one estrogen (listed first) and one progestin Drug to know: ethinyl
More informationAppendix A Materials Considered by Dr. Shelley Tischkau In addition to the materials specifically referenced in my report, the other materials I have considered are: Literature Editorial: Sex Hormone Binding
More informationCODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40
CODING GUIDELINES FOR CONTRACEPTIVES Effective June 1, 2017 Version 1.40 TABLE OF CONTENTS ICD-10 CM Diagnosis Codes: Encounter for Contraception page 2 Coding for IUD Insertion and Removal Procedures
More informationLong Acting Reversible Methods of Contraception (LARC) in Scotland
Publication Report Long Acting Reversible Methods of Contraception (LARC) in Scotland Year ending March 2015 Publication date 3 November 2015 A National Statistics Publication for Scotland Contents Introduction...
More informationRisk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare
Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare New data A paper published in May 2012 in the British Medical Journal
More informationContraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare
Contraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare Declaration of Competing Interests I have not received
More information3.0 FORMULARY LIST FOR USE IN FAMILY PLANNING
3.0 FORMULARY LIST FOR USE IN FAMILY PLANNING 2018 Provider Agreement Pharmacy Formulary NMDOH Family Planning Program Order questions: Joshua Rodriguez (505) 476-8350, Julie Roybal (505) 476-8362, or
More informationVolume 7; Number 17 October 2013
Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire
More informationPatient Group Direction for the administration of Levonorgestrel Emergency Contraception for Community Pharmacy
Patient Group Direction for the administration of Levonorgestrel for Community Pharmacy Author Corporate Lead Chris Toothill (Medicines Management Pharmacist, Governance and Risk, Leeds Community Healthcare
More informationContraception in Primary Care: Helping Your Patients Choose the Best Method
Friday CME Breakfast Contraception in Primary Care: Helping Your Patients Choose the Best Method Rebecca Hart, MD Family Physician, South Shore Medical Center Co Chair, 2017 Annual Session & Primary Care
More informationInstructions how to use the ESC teach the teachers course and self-learning tool
Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually
More informationCLINICAL PEARLS IN CONTRACEPTION
CLINICAL PEARLS IN CONTRACEPTION Laura Borgelt, PharmD, FCCP, BCPS Associate Professor University of Colorado Denver PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as
More informationTable I. Examples of Hormone and Tapering Regimens
Table I. Examples of Hormone and Tapering Regimens Severe AUB Heavy bleeding (soaking through 2 maxi pads an hour, 2 hours in a row) History of heavy menses Hemodynamically un (tachycardia, hypotensive,
More informationInstructions how to use the ESC teach the teachers course and self-learning tool
Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually
More informationEstrogens and progestogens
Estrogens and progestogens Estradiol and Progesterone hormones produced by the gonads are necessary for: conception embryonic maturation development of primary and secondary sexual characteristics at puberty.
More informationMenopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition
Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists
More informationMedical Eligibility for Contraception Use
Medical Eligibility for Contraception Use DIVISION OF REPRODUCTIVE HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC) Purpose To assist
More informationWhen talking about CHC it should not be forgotten that in addition to providing contraception this contraceptive method is associated with additional
1 2 When talking about CHC it should not be forgotten that in addition to providing contraception this contraceptive method is associated with additional health benefits. These benefits can be used to
More informationDeciding whether or not to use Hormone Therapy (HT) is a big decision and should be
Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be made with input from your healthcare provider. After the decision has been made to take HT, many women don t realize
More informationThis document will be updated as required.
This document will be updated as required. Last Update 27th May 2011 BNF CHAPTER 1 - GASTRO-INTESTINAL 1.1 Antacids (All available OTC) Co-Magaldrox - Low Na + - cheaper if prescribed as Mucogel Brand.
More informationCurrent approaches to managing heavy menstrual bleeding
Drug review Heavy menstrual bleeding Current approaches to managing heavy menstrual bleeding Jasmine Tay BM BS, Shruti Mohan MRCOG and Jenny Higham FRCOG SPL The choice of drug treatment for heavy menstrual
More informationFacts on Contraception and Abortion
Facts on Contraception and Abortion 1. Almost all modern contraceptives are in the World Health Organization's (WHO) Model List of Essential Medicines. The latest list of the WHO (2007, p. 109) include
More informationTaking provera with nexplanon
Taking provera with nexplanon The Borg System is 100 % Taking provera with nexplanon Aug 31, 2015. Side effects for everyone are different, and the amount of time that it takes for your body to get used
More informationFocus on long-acting reversible contraception 2015
Focus on long-acting reversible contraception 2015 Anita Sheetz, CNM, is an employee at the Mesa County Health Department working in the family planning and STD clinic. She has no financial disclosures.
More informationCONTRACEPTION IN HIV INFECTION DR JYOTI DHAR LEICESTER UK
CONTRACEPTION IN HIV INFECTION DR JYOTI DHAR LEICESTER UK Global figures Women account for 51.6% of HIV globally (15.9m of 30.8m HIV+ adults) UNAIDS report on the global AIDS epidemic, 2010 Estimated no.
More informationDEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL
DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS II. Under 10 United States
More informationLARC. sample. ask brook about. Are any of them right for me? How effective is it? How long does it last? long acting reversible contraception
72888_LARC:Layout 1 9/11/09 11:47 Page 1 Are any of them right for me? ask brook about LARC How effective is it? long acting reversible contraception How long does it last? 72888_LARC:Layout 1 9/11/09
More informationFuture methods of fertility regulation
Future methods of fertility regulation Catherine d Arcangues, d Ph.D., M.D. Department of Reproductive Health and Research World Health Organization CDA/HUG/MARCH 04 Contraceptive use % married women 15
More informationDr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre
Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre AUB Outline Terminology Classification/Etiology Assessment Treatment Referral to Gynaecology U c pt 4
More informationContraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital
Contraception: Common Problems Faced in Office Practice Jane S. Sillman, MD Brigham and Women s Hospital Disclosures I have no conflicts of interest Contraception: Common Problems How to discuss contraception
More informationWhat s New in Adolescent Contraception?
What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017 Objectives Provide an update on contraception options for the adolescent
More informationWhat size needle for depo provera
What size needle for depo provera The Borg System is 100 % What size needle for depo provera Jan 14, 2015. Nurse may administer Depo Provera in AIT, Same Day Clinic or by Nurse appointments. Equipment:
More informationMMPr001 EMERGENCY CONTRACEPTION PROTOCOL
MMPr001 EMERGENCY CONTRACEPTION PROTOCOL MMPr001 Emergency Contraception - (Sept18-Sept20) Page 1 of 8 Table of Contents MMPr001 EMERGENCY CONTRACEPTION PROTOCOL... 1 Why we need this protocol... 3 What
More information5. Summary of Data Reported and Evaluation
326 5. Summary of Data Reported and Evaluation 5.1 Exposure data Combined estrogen progestogen menopausal therapy involves the co-administration of an estrogen and a progestogen to peri- or postmenopausal
More informationQUESTIONS AND ANSWERS ON COMBINED HORMONAL CONTRACEPTIVES: LATEST INFORMATION FOR WOMEN
QUESTIONS AND ANSWERS ON COMBINED HORMONAL CONTRACEPTIVES: LATEST INFORMATION FOR WOMEN Why is new information being made available now? A recent Europe wide review looked at the benefits and risks of
More informationTeen Sexual Health Survey
Instructions Teen Sexual Health Survey Thank you for taking part in our survey. DO NOT write your name on this survey. The answers you give will be kept private. No one will know what you write. Answer
More informationMany women spend more than half of their approximately
n clinical n Budget Impact Analysis of 8 Hormonal Contraceptive Options Simone Crespi, MPH; Matthew Kerrigan, PhD; and Vipan Sood, MBA, MRPharmS, RPh Many women spend more than half of their approximately
More informationDOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code 1074g, as implemented
More information5. Summary of Data Reported and Evaluation
168 IARC MONOGRAPHS VOLUME 91 5. Summary of Data Reported and Evaluation 5.1 Exposure data The first oral hormonal contraceptives that were found to inhibit both ovulation and implantation were developed
More informationPower Point Use in EBPs. CAPP & PREP Learning Community May 15, 2018
Power Point Use in EBPs CAPP & PREP Learning Community May 15, 2018 Objectives Best practices for power point use Why use power point for EBP delivery Examples: the Good, the Bad and the Ugly Recommendations
More informationContraception for young people. Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015
Contraception for young people Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015 Learning objectives Be able to apply the principles of confidentiality, Fraser Guidelines, consent and safeguarding
More informationChoosing a Hormonal Contraceptive
PL Detail-Document #311001 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER October 2015 Choosing a Hormonal
More informationLEVONORGESTREL 1500 microgram tablets
Patient Group Direction for the supply of LEVONORGESTREL 1500 microgram tablets by Community Pharmacists Valid from: July 1 st 2014 Review: June 30 th 2015 Expiry date: June 30 th 2016 PGD Reference Number:
More informationPeggy Piascik, PhD Associate Professor, Pharmacy Practice and Science
Peggy Piascik, PhD Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy Describe extended cycle oral contraceptive characteristics including dosing regimen, indications,
More informationMalou Lindberg, Anniqa Foldemo, Ann Josefsson and Ann-Britt Wiréhn. Linköping University Post Print
Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: A nationwide population-based study with age-specific analyses Malou Lindberg,
More informationA Practitioner s Toolkit for the Management of the Menopause
Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash
More information4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms
550 4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms 4.1 Absorption, distribution, metabolism and excretion 4.1.1 Humans The pharmacokinetics of the newer progestogens, desogestrel,
More information